Heparin, Low-Molecular-Weight: all 55 studies that test it

Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.

• Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum ThrombosisRecruitingNCT07140211Phase 3
• Prevention of Postpartum Venous Thromboembolism in Women at Intermediate RiskRecruitingNCT06845423Phase 4
• A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer SurgeryNot yet recruitingNCT06583330Not applicable
• Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket TrialRecruitingNCT06381661Phase 2
• A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 PatientsRecruitingNCT06355258Phase 1
• Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)RecruitingNCT05604859Phase 4
• Chemoprophylaxis Plus Early AmbulationCompletedNCT03862755Phase 4Results posted
• PREVENTion of Clot in Orthopaedic TraumaCompletedNCT02984384Phase 3Results posted
• Role of Low-Molecular-Weight Heparin in Unexplained Recurrent Pregnancy LossCompletedNCT06484634Not applicable
• Thromboprophylaxis in Oesophageal Cancer PatientsStatus unknownNCT05067153Phase 4
• Low Molecular Weight hEparin vs. Aspirin Post-partumCompletedNCT05058924Not applicable
• Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced HypoxemiaCompletedNCT04990830Phase 2/3
• Low Molecular Weight Heparin on the Adenomyosis Patients'IVF-ET OutcomeStatus unknownNCT04741295Not applicable
• D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 PneumoniaStatus unknownNCT04584580Phase 4
• Reduced Anticoagulation Targets in ECLS (RATE)CompletedNCT04536272Phase 3
• Postoperative Thrombosis Prevention in Patients With CDActive, not recruitingNCT04486859Not applicable
• Ultra Low Doses of Therapy With Radiation Applicated to COVID-19SuspendedNCT04394182Not applicable
• Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary CatheterizationCompletedNCT04196309Phase 4
• Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous FistulaCompletedNCT04164693Not applicable
• Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial HypertensionCompletedNCT03963336Early Phase 1
• Effect of LMWH on Pregnancy Outcome in Women With Multiple Failures of IVF-ETStatus unknownNCT03701750Phase 4
• Treatment of Intrauterine Growth Restriction With Low Molecular Heparin.CompletedNCT03324139Phase 3
• Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction TreatmentStatus unknownNCT03230162Phase 3
• Low Molecular Weight Heparin for the Prevention of Early TIPS DysfunctionStatus unknownNCT03171727Not applicable
• Pregnancy Outcome of Women Using Low Molecular Weight Heparin Before Frozen-thawed Embryo TransferStatus unknownNCT03120715Phase 4
• Thromboprophylaxis After Surgery for Gynecologic Malignancy in ChinaCompletedNCT02935530Phase 3
• The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological MarkersCompletedNCT02861105Phase 4
• anti10a Levels in Women Treated With LMWH in the Postpartum PeriodCompletedNCT02856295Phase 4
• Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.CompletedNCT02834559Phase 3
• Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma.Status unknownNCT02715492Phase 3
• Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.Status unknownNCT01924104Phase 3
• Anticoagulation Length in Cancer Associated ThrombosisTerminatedNCT01817257Phase 2
• Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous AdministrationCompletedNCT01692171Phase 1
• Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single DoseCompletedNCT01692158Phase 1
• Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid AntibodiesCompletedNCT01608347Phase 4
• ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.Status unknownNCT01589146Phase 3
• Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg ImmobilisationCompletedNCT01542762Not applicable
• Pot-Kast: Thrombosis Prophylaxis After Knee ArthroscopyCompletedNCT01542723Not applicable
• Optimal Prophylactic Method of Venous Thromboembolism (VTE)Status unknownNCT01448746Phase 3
• Low Molecular Weight Heparin for Hemodialysis AnticoagulationCompletedNCT01356615Not applicable
• Role of Heparin in Poor Responders Undergoing In Vitro FertilisationCompletedNCT01315093Phase 2/3
• Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary EmbolismTerminatedNCT01164046Phase 3
• Study of Blood Clotting After Transcatheter Atrial Septal Defect ClosureStatus unknownNCT01086046Not applicable
• Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) ProphylaxisStatus unknownNCT01029821Not applicable
• PP13 and Doppler Study to Predict PreeclampsiaStatus unknownNCT00928213Phase 2/3
• The Role of Low Molecular Weight Heparins in Hepatocellular CarcinomaCompletedNCT00827554Phase 2/3
• Low Molecular Weight Heparin in Recurrent Implantation FailureCompletedNCT00750451Not applicable
• Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCTTerminatedNCT00564174Not applicable
• Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein ThrombosisStatus unknownNCT00450645Phase 4
• Deferment of Imaging for Pulmonary EmbolismCompletedNCT00381511Phase 4
• The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVRStatus unknownNCT00371020Phase 3
• Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)Status unknownNCT00370760Phase 3
• The HIT-TRAP TrialStatus unknownNCT00196417Phase 4
• The D-KAF (Dalteparin in Knee-to-Ankle Fracture) TrialCompletedNCT00187408Phase 4
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)CompletedNCT00182143Phase 3

← Heparin, Low-Molecular-Weight overview